Sparsha Pharma launches new-generation transdermal patches for effective pain management

2024-04-14 03:23:39 Health and Fitness

571

Sparsha Pharma launches new-generation transdermal patches for effective pain management

Artho-Touch TM and Diclo-Touch TM patches unveiled by Andhra Health Minister Shri. D.L. Ravindra Reddy

Hyderabad, September 30th, 2011: Scores of patients in India depend upon their daily dose of analgesics either in form of oral medication or injections to subside their intense pain. To help such patients Sparsha Pharma International Pvt. Ltd, India?s first WHO certified Fentanyl Transdermal Patch manufacturing company, today launched two new-generation transdermal patches meant for effective pain management.

Chief Guest Shri. D.L. Ravindra Reddy, Hon?ble Medical & Health Minister of Andhra Pradesh, unveiled Artho-Touch TM and Diclo-Touch TM transdermal patches at a press conference here. Also present at the launch were Guests of Honor ? Dr. A.V. Gurava Reddy, CEO Sunshine Hospital and Dr. V. Sarath Chandra Mouli, Chief Rheumatologist, KIMS Hospital, Dr. Dange Veerapaneni, Managing Director, Sparsha Pharma and Mr. Rajeev Sindhi, Managing Director, Sandor Medicaids, the marketing and distribution partner for the new products.

Ailments such as Tennis elbow, Arthritis Deformans (chronic form of arthritis), Peritendinitis (swelling of tendons), pain after trauma, shoulder blade pain, neck pain, back pain, Myalgia (muscle pain), Spondylitis (swelling of vertebrae), menstrual pains etc are often intensely painful conditions that afflict scores of men and women. Patients are often required to take large doses of painkillers either orally or intravenously (through injection) to get relief from their condition.

However, long term use of painkillers in form of oral medication may have serious systemic side effects. Also, many patients find it difficult to take measured doses of these medicines on their own. For such patients transdermal patches are the best answer. These ensure long lasting controlled release of the drug into the body. The design of Artho-Touch TM and Diclo-Touch TM patches is such that these can be comfortably worn on the skin. These are easy to apply and remove. These products have flexibility due to elastic fabric backing.
Speaking on the launch, Dr. Dange, said, ?Transdermal patches are an effective mode of drug delivery into the human body. Since they are equipped to release controlled doses of the drug/painkiller medicine, they help in an effective management of pain. Sparsha Pharma?s transdermal patches Artho-Touch and Diclo-Touch have advanced designs. Also, these are esthetically acceptable and are capable of delivering sustained dosing of active compounds. These products will tremendously benefit patients who have developed painful conditions such as Myalgia, shoulder pain, neck pain etc. owing to their poor lifestyle habits.?
Both these products have long-lasting application and do not lead to any kind of gastric irritation or systemic side effects of drugs taken orally. They are so designed to effectively deliver the drug directly into the wearer?s bloodstream/tissue.

About Sparsha Pharma
Sparsha Pharma International Pvt. Ltd. is India's first WHO certified Fentanyl Transdermal Patch manufacturing company. Sparsha Pharma is engaged in Research & Development, Manufacturing and Marketing of transdermal drug delivery products for the global markets. The company was founded in 2008 with a mission to contribute to the wellbeing of patients through innovative, safe, effective and affordable transdermal products. Sparsha Pharma collaborates with other companies and universities in order to improve its activities in research and development, production, marketing and contract manufacturing. For more information visit: www.sparsha.com
For further queries please contact: Dr. Dange Veerapaneni : 040 23352581 / 09963770793